CTRI/2017/08/009405
Recruiting
N/A
Comparison of Genetic risk factors in young Onset Myocardial Infarction versus old Onset Myocardial Infarction.
Med Genome PVT Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Adult individuals who will be admitted to the hospital for YOMI and OOMI.
- Sponsor
- Med Genome PVT Ltd
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •those who had YOMI(young onset Myocardial Infarction) and OOMI( old onset Myocardial Infarction) in the past and will be visiting the outpatient department for the follow up also will be included.
Exclusion Criteria
- •1\.Participants who do not provide DNA with sufficient quantity or quality for genotyping.
- •2\.Participants with missing information about established risk factors.
- •3\.Participants with missing genotypes for more than 10 SNPs out of the list of 50 SNPs given.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
The impact of genetic predisposition in pediatric renal cancer: genotypic and phenotypic characterizatioNL-OMON46432Prinses Máxima Centrum voor Kinderoncologie120
Recruiting
N/A
Genetic analysis of prognosis-related factors in gliomas: methylation of MGMT, LOH of 1p/19q, and mutation of IDH1/2.GliomaJPRN-UMIN000003196Yokohama City University of Medicine100
Completed
Phase 4
Investigation of Genetic Predictors of the Response to Selective Serotonin Re-Uptake Inhibitors TreatmentDepressionAntidepressantTreatment predictionMental Health - DepressionACTRN12609000295246Tartu University135
Completed
N/A
Identifying genetic and metabolic risk factors for mild non-specific mental retardation and borderline intellectual functioning in parent offspring trios.1. mild non-specific mental retardation and borderline intelligence 2. mild intellectual disability10029299NL-OMON34844Vrije Universiteit Medisch Centrum3,000
Completed
N/A
Exploratory Study of Genetic Factors Related to the Inhibitory Effect of Tolvaptan on Increased Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney DiseaseAutosomal Dominant Polycystic Kidney DiseaseJPRN-UMIN000031976Otsuka Pharmaceutical Co.,Ltd.890